Your browser doesn't support javascript.
loading
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2.
Yang, Michael G; Xiao, Zili; Zhao, Rulin; Tebben, Andrew J; Wang, Bei; Cherney, Robert J; Batt, Douglas G; Brown, Gregory D; Cvijic, Mary Ellen; Duncia, John V; Gallela, Michael A; Gardner, Daniel S; Khandelwal, Purnima; Malley, Mary F; Pang, Jian; Rose, Anne V; Santella, Joseph B; Sarjeant, Amy A; Xu, Songmei; Mathur, Arvind; Mandlekar, Sandhya; Vuppugalla, Ragini; Zhao, Qihong; Carter, Percy H.
Afiliación
  • Yang MG; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Xiao Z; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Zhao R; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Tebben AJ; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Wang B; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Cherney RJ; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Batt DG; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Brown GD; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Cvijic ME; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Duncia JV; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Gallela MA; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Gardner DS; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Khandelwal P; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Malley MF; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Pang J; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Rose AV; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Santella JB; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Sarjeant AA; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Xu S; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Mathur A; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Mandlekar S; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Vuppugalla R; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Zhao Q; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
  • Carter PH; Research and Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543-4000, United States.
ACS Med Chem Lett ; 12(6): 969-975, 2021 Jun 10.
Article en En | MEDLINE | ID: mdl-34141082
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos